Arthur J. Gallagher & Co.

(New York Stock Exchange)
Back to all articles
Bullish +65

Arthur J. Gallagher & Co. Stock (AJG) Opinions on Analyst Upgrades - Quiver Quantitative

AI-generated analysis

πŸ“ˆ UBS upgraded AJG to Buy from Neutral, citing robust expectations for commercial reinsurance volumes and sustained demand.

πŸš€ Jefferies raised its price target to $265.00 and maintained a Buy rating, noting operational resilience and share gains.

πŸ’° Evercore highlighted AJG's long track record as a standout asset amid potential margin pressures on competitors.

πŸ“‰ CEO J. Patrick Gallagher sold 27,450 shares for an estimated $6.3 million over the past six months.

πŸ“Š Q1 2026 revenues reached $4.8 billion, marking a 27.65% increase compared to the same period in the prior year.

🏦 Dodge & Cox added 6.47 million shares (+735.2%) to its portfolio in Q1 2026, valuing the position at over $1.4 billion.

πŸ“‰ Morgan Stanley removed 3.72 million shares (-47.8%) from its portfolio in Q1 2026, reducing exposure by roughly $805 million.

🎯 The median analyst price target for AJG is set at $259.00 based on inputs from 13 analysts over the last six months.

βš–οΈ Analyst ratings are mixed with four firms issuing Buy/Overweight ratings against one firm issuing a Sell/Underweight rating.

πŸ›οΈ Congressional trading data shows net selling activity, with Representative Kelly Morrison making three sales totaling up to $80,000.

Bullish Signals
  • UBS upgraded the stock to Buy from Neutral, explicitly citing robust expectations for commercial reinsurance volumes and alignment with sustained demand in key segments.
  • Jefferies raised its price target to $265.00 (from $235.00) and maintained a Buy rating, highlighting consistent share gains and operational resilience as signs of strengthening fundamentals.
  • Evercore analysts identified AJG as standing out with a long track record, specifically noting its strength relative to peers facing potential margin pressures.
  • The company reported strong financial performance with Q1 2026 revenues reaching $4.8 billion, an increase of 27.65% from the prior year's same period.
  • Significant institutional accumulation occurred with Dodge & Cox adding over 6.47 million shares (+735.2%) to its portfolio in Q1 2026.
Risk Factors
  • Insider selling activity is notable, with CEO J. Patrick Gallagher and General Counsel Walter D. Bay collectively selling over $10 million worth of stock in the past six months.
  • Major institutional investors reduced positions significantly, including Morgan Stanley removing 3.72 million shares (-47.8%) and Capital International Investors reducing holdings by 58.7%.
  • Analyst price targets show a range of dispersion, with Piper Sandler setting a target of $211.00 and Truist Securities at $225.00, which are below the median target of $259.00.
  • One firm, Barclays, issued an 'Underweight' rating on January 8, 2026, providing a bearish counterpoint to the recent upgrades from UBS and Jefferies.
Full Analysis
Arthur J. Gallagher & Co. (AJG) is receiving significant analyst attention following upgrades from major firms like UBS and Jefferies, which have raised their ratings to Buy and price targets respectively. UBS cited robust expectations for commercial reinsurance volumes, while Jefferies highlighted the company's consistent share gains and operational resilience as signals of strengthening fundamentals heading into the second half of the year. The article details a mixed landscape of insider and institutional activity surrounding AJG. While CEO J. Patrick Gallagher and several other executives have sold shares over the past six months, institutional investors show divergent views; Dodge & Cox significantly increased its position by over 735% in Q1 2026, whereas major firms like Morgan Stanley and Capital International Investors reduced their holdings substantially. Financially, AJG reported revenues of $4.8 billion for the first quarter of 2026, representing a 27.65% increase year-over-year. Wall Street consensus remains largely positive with a median price target of $259.00 from 13 analysts, though some targets range lower at $211.00. The company maintains a strong track record despite potential margin pressures facing peers in the sector.